MedTrace Logo

For Her Heart's Sake STEP Project: A Clinical Trial

NCT02411188 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-11-02

No results posted yet for this study

Summary

The goal of the proposed project is to determine if providing an intervention for women who decline the invitation to participate in standard cardiac rehabilitation programs (CRPs) will ultimately result in an increase their participation in CRPs.This study will evaluate outcomes of patients randomized to the FHHS STEP Program versus by non-STEP Program participants. The overall goal is to provide an alternate, introductory program that will engage, educate, and empower women following a cardiac event. Providing these women with the necessary personal resources will encourage and enable these women to take the step towards a cardiac rehabilitation program, which, in turn will ideally lead to a life-long commitment to heart health.

Conditions

Interventions

BEHAVIORAL

The STEP Program

Intervention: The 12-week STEP Program will include: initial individual consult/goal setting; weekly 90 minute information/interactive sessions; individualized patient centred care; journaling

Sponsors & Collaborators

  • Victoria General Hospital Foundation

    collaborator UNKNOWN

  • Reh-Fit Fitness Centre

    collaborator UNKNOWN

  • Wellness Institute-Seven Oaks General Hospital

    collaborator UNKNOWN

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Jo-Ann V Sawatzky, RN, PhD · University of Manitoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-03-31
Completion
2018-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02411188 on ClinicalTrials.gov